Tranzactioneaza Vaxart Inc (US.VXRT) - 0.57 USD (%) Tranzactioneaza
Indici
Descriere companie
Vaxart, Inc. (https://vaxart.com/) is a clinical-stage biotechnology company. It is focused on developing oral recombinant vaccines based on its Vector-Adjuvant-Antigen Standardized Technology (VAAST) oral vaccine platform. Its oral vaccines are designed to generate immune responses that protect against a range of infectious diseases and will be useful for the treatment of chronic viral infections and cancer. It is developing prophylactic vaccine candidates that target a range of infectious diseases, including SARS-CoV-2, norovirus, seasonal influenza and respiratory syncytial virus (RSV). It is also developing therapeutic vaccine targeting cervical cancer and dysplasia caused by human papillomavirus (HPV). Its therapeutic oral vaccine candidate targets HPV-16 and HPV-18, the two strains responsible for cervical cancers and precancerous cervical dysplasia. It uses a short section of double-stranded ribonucleic acid RNA (dsRNA) as an adjuvant to improve the immunogenicity of its tablet vaccine candidates.